Supervised Machine Learning and Logistic Regression Identifies Novel Epistatic Risk Factors with PTPN22 for Rheumatoid Arthritis

Overview

Journal Genes Immun

Date 2010 Jan 22

PMID 20090771

Citations 20

Authors

F B S Briggs

P P Ramsay

E Madden

J M Norris

V M Holers

T R Mikuls

T Sokka

M F Seldin

P K Gregersen

L A Criswell

L F Barcellos

Affiliations

Soon will be listed here.

Abstract

Investigating genetic interactions (epistasis) has proven difficult despite the recent advances of both laboratory methods and statistical developments. With no 'best' statistical approach available, combining several analytical methods may be optimal for detecting epistatic interactions. Using a multi-stage analysis that incorporated supervised machine learning and methods of association testing, we investigated epistatic interactions with a well-established genetic factor (PTPN22 1858T) in a complex autoimmune disease (rheumatoid arthritis (RA)). Our analysis consisted of four principal stages: Stage I (data reduction)-identifying candidate chromosomal regions in 292 affected sibling pairs, by predicting PTPN22 concordance using multipoint identity-by-descent probabilities and a supervised machine learning algorithm (Random Forests); Stage II (extension analysis)-testing detailed genetic data within candidate chromosomal regions for epistasis with PTPN22 1858T in 677 cases and 750 controls using logistic regression; Stage III (replication analysis)-confirmation of epistatic interactions in 947 cases and 1756 controls; Stage IV (combined analysis)-a pooled analysis including all 1624 RA cases and 2506 control subjects for final estimates of effect size. A total of seven replicating epistatic interactions were identified. SNP variants within CDH13, MYO3A, CEP72 and near WFDC1 showed significant evidence for interaction with PTPN22, affecting susceptibility to RA.

Citing Articles

Scoping review: Machine learning interventions in the management of healthcare systems.

Arueyingho O, Al-Taie A, McCallum C Digit Health. 2024; 10:20552076221144095.

PMID: 39444734 PMC: 11497546. DOI: 10.1177/20552076221144095.

Distributed transformer for high order epistasis detection in large-scale datasets.

Graca M, Nobre R, Sousa L, Ilic A Sci Rep. 2024; 14(1):14579.

PMID: 38918413 PMC: 11199512. DOI: 10.1038/s41598-024-65317-5.

Prediction of Liver Enzyme Elevation Using Supervised Machine Learning in Patients With Rheumatoid Arthritis on Treatment with Methotrexate.

Surendran S, B M, Gilvaz V, Manyam P, Panicker K, Pradeep M Cureus. 2024; 16(1):e52110.

PMID: 38344615 PMC: 10858738. DOI: 10.7759/cureus.52110.

Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review.

Momtazmanesh S, Nowroozi A, Rezaei N Rheumatol Ther. 2022; 9(5):1249-1304.

PMID: 35849321 PMC: 9510088. DOI: 10.1007/s40744-022-00475-4.

Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs).

De Cock D, Myasoedova E, Aletaha D, Studenic P Ther Adv Musculoskelet Dis. 2022; 14:1759720X221105978.

PMID: 35794905 PMC: 9251966. DOI: 10.1177/1759720X221105978.

References

Ma L, Dvorkin D, Garbe J, Da Y . Genome-wide analysis of single-locus and epistasis single-nucleotide polymorphism effects on anti-cyclic citrullinated peptide as a measure of rheumatoid arthritis. BMC Proc. 2008; 1 Suppl 1:S127. PMC: 2367477. DOI: 10.1186/1753-6561-1-s1-s127. View

Philippova M, Ivanov D, Allenspach R, Takuwa Y, Erne P, Resink T . RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin. FASEB J. 2005; 19(6):588-90. DOI: 10.1096/fj.04-2430fje. View

Musani S, Shriner D, Liu N, Feng R, Coffey C, Yi N . Detection of gene x gene interactions in genome-wide association studies of human population data. Hum Hered. 2007; 63(2):67-84. DOI: 10.1159/000099179. View

Pritchard J, Stephens M, Rosenberg N, Donnelly P . Association mapping in structured populations. Am J Hum Genet. 2000; 67(1):170-81. PMC: 1287075. DOI: 10.1086/302959. View

Criswell L, Pfeiffer K, Lum R, Gonzales B, Novitzke J, Kern M . Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005; 76(4):561-71. PMC: 1199294. DOI: 10.1086/429096. View

Arechiga A, Habib T, He Y, Zhang X, Zhang Z, Funk A . Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol. 2009; 182(6):3343-7. PMC: 2797545. DOI: 10.4049/jimmunol.0713370. View

Schellekens G, Visser H, de Jong B, van den Hoogen F, Hazes J, Breedveld F . The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000; 43(1):155-63. DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. View

Alvarez R, Reading J, King D, Hayes M, Easterbrook P, Farzaneh F . WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection. J Virol. 2007; 82(1):471-86. PMC: 2224370. DOI: 10.1128/JVI.00939-07. View

MacGregor A, Snieder H, Rigby A, Koskenvuo M, Kaprio J, Aho K . Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000; 43(1):30-7. DOI: 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B. View

10.

Elwany S, El Garf A, Kamel T . Hearing and middle ear function in rheumatoid arthritis. J Rheumatol. 1986; 13(5):878-81. View

11.

Harrison P, Pointon J, Farrar C, Brown M, Wordsworth B . Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford). 2006; 45(8):1009-11. DOI: 10.1093/rheumatology/kei250. View

12.

Cordell H . Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009; 10(6):392-404. PMC: 2872761. DOI: 10.1038/nrg2579. View

13.

Jawaheer D, Li W, Graham R, Chen W, Damle A, Xiao X . Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet. 2002; 71(3):585-94. PMC: 449696. DOI: 10.1086/342407. View

14.

Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S . From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci U S A. 2002; 99(11):7518-23. PMC: 124268. DOI: 10.1073/pnas.102091699. View

15.

Markianos K, Daly M, Kruglyak L . Efficient multipoint linkage analysis through reduction of inheritance space. Am J Hum Genet. 2001; 68(4):963-77. PMC: 1275650. DOI: 10.1086/319507. View

16.

Plenge R, Seielstad M, Padyukov L, Lee A, Remmers E, Ding B . TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med. 2007; 357(12):1199-209. PMC: 2636867. DOI: 10.1056/NEJMoa073491. View

17.

Sokka T, Pincus T . An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S178-81. View

18.

Murdin L, Patel S, Walmsley J, Yeoh L . Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol. 2007; 27(5):637-40. DOI: 10.1007/s10067-007-0802-z. View

19.

Vang T, Congia M, Macis M, Musumeci L, Orru V, Zavattari P . Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 2005; 37(12):1317-9. DOI: 10.1038/ng1673. View

20.

Costenbader K, Chang S, De Vivo I, Plenge R, Karlson E . Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther. 2008; 10(3):R52. PMC: 2483441. DOI: 10.1186/ar2421. View